Biohope will present a poster in the framework of the BST (Basic Science in Transplantation) congress that takes place from October 11th to 13th in Rotterdam. It shows the biotechnological principles of the Immunobiogram (IMBG) and the results of the clinical study BH-Pilot, in which the IMBG was tested in 70 patients with a renal [...]
"Closer to the personalization of renal transplant treatment. First study to evaluate the functionality of the immunobiogram to predict the immunosuppressive response." > Read More
Isabel talks about the way she has professionally evolved, the achievements she has made and the promising future of Biohope, a highly qualified innovative Clinical stage biotech Company, thanks to the enthusiasm, ability to work together , and a shared vision of her and her team. > Read the article in Womenalia
Following the presentation of Biohope at the Congress of the International Society of Transplantation held in Madrid, the media have published different articles on the results of the clinical study that demonstrate the usefulness of the Immunobiogram. Diario medico 'Antibiogram of immunity' for rejection in kidney graft" >Read Article (pdf) Diario Médico.com > Read Article [...]
The TRANSBIO clinical study has started with inclusion of the first patient in the Hospital Puerta de Hierro (Madrid, Spain) on the 12th of June 2018, with Dr. José María Portoles as Principal Investigator. The University Hospital Puerta de Hierro was created in 1964 and it is a general hospital of first level that fulfils a triple function: [...]
BIOHOPE recently presented the first data of their pilot study "BH-Pilot", at an investigator meeting with their Scientific Advisory Board held in the context of the European Society of Organ Transplantation (Barcelona, 24-27 September 2017). The study is being developed in collaboration with the Hospital Puerta de Hierro and La Paz University Hospital, both in [...]